Stay updated on pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.

Latest updates to the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page
- Check5 days agoChange DetectedA site-wide NIH notice about terminology changes appears above the page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check33 days agoChange DetectedThe study page now returns a 403 Forbidden error, replacing the detailed study record with an access-denied page. This prevents users from viewing the NCT03600350 study details and related information.SummaryDifference19%

- Check40 days agoChange DetectedA new revision note, v3.7.0, was added and the older revision note v3.6.6 was removed. The Prostate cancer topic and the related topics tag MedlinePlus Genetics were removed, indicating an update to metadata rather than core content.SummaryDifference0.2%

- Check47 days agoChange DetectedAdds related topics entries: Prostate cancer and MedlinePlus Genetics, improving topic tagging and discoverability of the study page.SummaryDifference0.2%

- Check54 days agoChange DetectedUpdated the page revision from v3.6.5 to v3.6.6, signaling a minor update to the page's documentation or rendering. The change does not alter the study content or user-facing features.SummaryDifference0.1%

Stay in the know with updates to pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.